SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-002913
Filing Date
2023-03-06
Accepted
2023-03-06 16:12:43
Documents
103
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cara-20221231x10k.htm   iXBRL 10-K 3600704
2 EX-23.1 cara-20221231xex23d1.htm EX-23.1 13272
3 EX-31.1 cara-20221231xex31d1.htm EX-31.1 11580
4 EX-31.2 cara-20221231xex31d2.htm EX-31.2 11743
5 EX-32.1 cara-20221231xex32d1.htm EX-32.1 10305
6 GRAPHIC cara-20221231x10k004.jpg GRAPHIC 55268
  Complete submission text file 0001558370-23-002913.txt   14765422

Data Files

Seq Description Document Type Size
7 EX-101.SCH cara-20221231.xsd EX-101.SCH 89372
8 EX-101.CAL cara-20221231_cal.xml EX-101.CAL 75572
9 EX-101.DEF cara-20221231_def.xml EX-101.DEF 465897
10 EX-101.LAB cara-20221231_lab.xml EX-101.LAB 729929
11 EX-101.PRE cara-20221231_pre.xml EX-101.PRE 659263
97 EXTRACTED XBRL INSTANCE DOCUMENT cara-20221231x10k_htm.xml XML 2700509
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36279 | Film No.: 23709068
SIC: 2834 Pharmaceutical Preparations